Table 1.
Gene and mutant | NTD Type | Penetrance | References |
---|---|---|---|
Vangl2Lp/+, Dvl2−/− | CRN | 100% | Wang et al. (2006) [25] |
Vangl2Lp/+, Dvl3+/− | CRN, EX | 30% | Etheridge et al. (2008) [26] |
Vangl2Lp/+,ScribCrc/+ | CRN or SB | 55% CRN, 5% SB | Murdoch et al. (2001) [27] |
Vangl2Lp/+,ScribCrc/+ | CRN | 54% | Murdoch et al. (2014) [2] |
Vangl2Lp/+,Celsr1Crsh/+ | CRN | not stated | Copp et al. (2003) [41] |
Vangl2Lp/+,Celsr1Crsh/+ | CRN | 54% | Murdoch et al. (2014) [2] |
Vangl2Lp/+, Ptk7+/− | SB | 95% | Lu et al. (2004) [47] |
Vangl2Lp/+,Vangl1+/− | CRN | 60% | Torban et al. (2008) [28] |
Dvl2−/−,Dvl3+/− | CRN | ~100% | Etheridge et al. (2008) [26] |
Dvl2+/−,Dvl3−/− | CRN | some | Etheridge et al. (2008) [26] |
ScribCrc/+,Celsr1Crsh/+ | CRN | 8% | Murdoch et al. (2014) [2] |
PCP, planar cell polarity; NTD, neural tube defect; CRN, craniorachischisis; SB, spina bifida; EX, exencephaly.